140 related articles for article (PubMed ID: 19536119)
21. Personalized medicine: are we there yet?
Ikediobi ON
Pharmacogenomics J; 2009 Apr; 9(2):85. PubMed ID: 18794909
[No Abstract] [Full Text] [Related]
22. [Rare diseases: specific ethical and legal aspects of genetic counseling and screening].
Sánchez-Caro J
Rev Derecho Genoma Hum; 2011; (35):115-41. PubMed ID: 22984752
[TBL] [Abstract][Full Text] [Related]
23. Technology and the boundaries of the hospital: three emerging technologies.
Goldsmith J
Health Aff (Millwood); 2004; 23(6):149-56. PubMed ID: 15537593
[TBL] [Abstract][Full Text] [Related]
24. Breaking the code. When bill barring genetic discrimination is signed into law, 'fear of repercussions' will dissipate among patients: expert.
Vesely R
Mod Healthc; 2008 May; 38(19):6-7, 16, 1. PubMed ID: 18543820
[TBL] [Abstract][Full Text] [Related]
25. Direct to consumer genetic tests.
Patch C; Sequeiros J; Cornel MC
Eur J Hum Genet; 2009 Sep; 17(9):1111. PubMed ID: 19401718
[No Abstract] [Full Text] [Related]
26. Genetic nondiscrimination legislation could improve cancer prevention--if it passes.
Beckman M
J Natl Cancer Inst; 2007 Jul; 99(13):993-5. PubMed ID: 17596565
[No Abstract] [Full Text] [Related]
27. ONA sponsors patient protection legislation.
Okla Nurse; 1999; 44(1):1. PubMed ID: 12017558
[No Abstract] [Full Text] [Related]
28. Family-based screening for colorectal cancer: The Australian perspective.
Leggett BA
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
[TBL] [Abstract][Full Text] [Related]
29. Progress toward personalized medicine for age-related macular degeneration.
Moroi SE; Heckenlively JR
Ophthalmology; 2008 Jun; 115(6):925-6. PubMed ID: 18519068
[No Abstract] [Full Text] [Related]
30. Which way for genetic-test regulation? Assign regulation appropriate to the level of risk.
Javitt G
Nature; 2010 Aug; 466(7308):817-8. PubMed ID: 20703288
[No Abstract] [Full Text] [Related]
31. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
Issa AM
Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
[TBL] [Abstract][Full Text] [Related]
32. Genetic risk assessment, counseling and testing.
Rich TA; Salazar M
Surg Oncol Clin N Am; 2009 Jan; 18(1):19-38, vii. PubMed ID: 19056040
[TBL] [Abstract][Full Text] [Related]
33. The dangers of diagnostic monopolies.
Cook-Deegan R; Chandrasekharan S; Angrist M
Nature; 2009 Mar; 458(7237):405-6. PubMed ID: 19325608
[No Abstract] [Full Text] [Related]
34. The modern haemodialysis factory: Must quality improvement trump personalized care?
Marcelli D; Richards N; Amato C
Nephrol Dial Transplant; 2008 Jul; 23(7):2433; author reply 2433-4. PubMed ID: 18436561
[No Abstract] [Full Text] [Related]
35. Which way for genetic-test regulation? Leave test interpretation to specialists.
Beaudet AL
Nature; 2010 Aug; 466(7308):816-7. PubMed ID: 20703287
[No Abstract] [Full Text] [Related]
36. Personalized medicine: reality and reality checks.
Leeder JS; Spielberg SP
Ann Pharmacother; 2009 May; 43(5):963-6. PubMed ID: 19417116
[TBL] [Abstract][Full Text] [Related]
37. Justice in action? Introduction to the mini symposium on Norman Daniels' Just health: meeting health needs fairly.
Rid A; Biller-Andorno N
J Med Ethics; 2009 Jan; 35(1):1-2. PubMed ID: 19103933
[No Abstract] [Full Text] [Related]
38. Controversies in communication of genetic risk for hereditary breast cancer.
Mackenzie A; Patrick-Miller L; Bradbury AR
Breast J; 2009; 15 Suppl 1():S25-32. PubMed ID: 19775327
[TBL] [Abstract][Full Text] [Related]
39. Ethical and practical challenges surrounding genetic and genomic research in developing countries.
Nyika A
Acta Trop; 2009 Nov; 112 Suppl 1():S21-31. PubMed ID: 19665983
[TBL] [Abstract][Full Text] [Related]
40. Genetic testing: considerations for pediatric nephrologists.
Guay-Woodford LM; Knoers NV
Semin Nephrol; 2009 Jul; 29(4):338-48. PubMed ID: 19615555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
